Onychomycosis (Tinea Unguium) Market 2018 : Hexima Ltd Kaken, Pharmaceutical Co Ltd, Meiji Seika Pharma Co Ltd, and Moberg.

Onychomycosis (Tinea Unguium)

Overview

Onychomycosis is a chronic fungal infection of the nails caused by dermatophytes. Symptoms include thickened nail that is difficult to cut, brittle or ragged nail, discolored or unsightly nail and pain of the finger or toe with ordinary activities. Treatment includes antifungal medications and surgery.

Onychomycosis which is also known as fungal infection of the nails is somewhat uncommon during childhood. After puberty, its frequency increases with age. Usually, Onychomycosis is associated with tinea pedis.

Click here for sample report @ https://www.wiseguyreports.com/sample-request/2811469-onychomycosis-tinea-unguium-pipeline-review-h1-2018

Onychomycosis (Tinea Unguium) Industry Major Highlights:

Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Onychomycosis (Tinea Unguium) (Infectious Disease), drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The report further guide in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Onychomycosis (Tinea Unguium) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Apart from this various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Major Outlook for Onychomycosis (Tinea Unguium) Report:

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Onychomycosis (Tinea Unguium) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Onychomycosis (Tinea Unguium) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Onychomycosis (Tinea Unguium)

The pipeline guide provides a snapshot of the global therapeutic landscape of Onychomycosis (Tinea Unguium).

- The pipeline guide reviews pipeline therapeutics for Onychomycosis (Tinea Unguium) by companies and universities/research institutes based on information derived from company and industry-specific sources.

Competitive Analysis for Onychomycosis (Tinea Unguium)

Key players are making innovative developments in Onychomycosis (Tinea Unguium) industry. The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector.

The key players in this market are Almirall SA, Blueberry Therapeutics Ltd, Dermala Inc, Eisai Co Ltd, Helix BioMedix Inc, Hexima Ltd Kaken, Pharmaceutical Co Ltd, Meiji Seika Pharma Co Ltd, and Moberg. 

….. Continued

Table of Contents

Introduction 5

Global Markets Direct Report Coverage 5

Onychomycosis (Tinea Unguium) - Overview 6

Onychomycosis (Tinea Unguium) - Therapeutics Development 7

Pipeline Overview 7

Pipeline by Companies 8

Products under Development by Companies 10

Onychomycosis (Tinea Unguium) - Therapeutics Assessment 11

Assessment by Target 11

Assessment by Mechanism of Action 13

Assessment by Route of Administration 15

Assessment by Molecule Type 17

Onychomycosis (Tinea Unguium) - Companies Involved in Therapeutics Development 19

ActiveSite Pharmaceuticals Inc 19

Coherus BioSciences Inc 19

Lupin Ltd 20

Mabion SA 20

....

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/2811469-onychomycosis-tinea-unguium-pipeline-review-h1-2018

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)